MedTrace Logo

Esketamine vs Remimazolam for Postoperative Sleep Disturbance and Anxiety

NCT06284668 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 315

Last updated 2025-11-26

No results posted yet for this study

Summary

To explore and compare the effects of esketamine and remimazolam on postoperative sleep disturbance in patients undergoing oocyte retrieval

Conditions

  • Sleep Disturbance

Interventions

DRUG

normal Saline

Patients undergoing oocyte retrieval were given 5ml 0.9% saline before anesthesia and surgery

DRUG

Esketamine

Patients undergoing oocyte retrieval were given esketamine 0.2mg/kg before anesthesia and surgery

DRUG

Remimazolam

Patients undergoing oocyte retrieval were given remimazolam 0.2mg/kg before anesthesia and surgery

Sponsors & Collaborators

  • Tianjin Medical University General Hospital

    lead OTHER

Principal Investigators

  • Guolin Wang · Tianjin Medical University General Hospital

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-04
Primary Completion
2025-05-10
Completion
2025-05-20

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06284668 on ClinicalTrials.gov